James A. Lyon

543 total citations
15 papers, 335 citations indexed

About

James A. Lyon is a scholar working on Pharmacology, Epidemiology and Surgery. According to data from OpenAlex, James A. Lyon has authored 15 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in James A. Lyon's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (3 papers). James A. Lyon is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Pneumonia and Respiratory Infections (3 papers) and Antibiotic Resistance in Bacteria (3 papers). James A. Lyon collaborates with scholars based in United States, Egypt and Belgium. James A. Lyon's co-authors include Pamela D. Garzone, Victor L. Yu, Donald C. McLeod, Stephen J. Peroutka, James Swarbrick, Victor L. Yu, John R. Zuniga, Gene E. Watson, Daniel A. Shugars and Theodore A. Kiersch and has published in prestigious journals such as Radiology, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

James A. Lyon

15 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Lyon United States	10	150	83	80	53	37	15	335
R Münch Switzerland	10	63 0.4×	49 0.6×	119 1.5×	31 0.6×	20 0.5×	42	292
C. F. Speirs United Kingdom	11	73 0.5×	27 0.3×	40 0.5×	16 0.3×	53 1.4×	18	393
Douglas Allington United States	10	39 0.3×	41 0.5×	82 1.0×	16 0.3×	53 1.4×	13	399
J. I. Dahlager Denmark	7	132 0.9×	49 0.6×	38 0.5×	35 0.7×	56 1.5×	18	354
R W Schultz United States	8	155 1.0×	75 0.9×	137 1.7×	68 1.3×	43 1.2×	9	377
R J Stead United Kingdom	14	27 0.2×	54 0.7×	95 1.2×	20 0.4×	27 0.7×	21	524
P. Olschewski Germany	11	220 1.5×	119 1.4×	233 2.9×	92 1.7×	55 1.5×	22	528
H. Haller Germany	9	77 0.5×	52 0.6×	37 0.5×	15 0.3×	33 0.9×	20	247
Amirhooshang Mohammadpour Iran	7	175 1.2×	64 0.8×	45 0.6×	15 0.3×	43 1.2×	11	416
Marianne Pilet Switzerland	7	45 0.3×	53 0.6×	39 0.5×	31 0.6×	23 0.6×	9	354

Countries citing papers authored by James A. Lyon

Since Specialization

Citations

This map shows the geographic impact of James A. Lyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Lyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Lyon more than expected).

Fields of papers citing papers by James A. Lyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Lyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Lyon. The network helps show where James A. Lyon may publish in the future.

Co-authorship network of co-authors of James A. Lyon

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Lyon. A scholar is included among the top collaborators of James A. Lyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Lyon. James A. Lyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lyon, James A., et al.. (2025). Prognostic Role of MTAP Loss in Cholangiocarcinoma. JCO Precision Oncology. 9(9). e2400842–e2400842. 1 indexed citations

Vodkin, Irine, Robert Newbury, Vera Vavinskaya, et al.. (2019). Evaluation of Fontan liver disease: Correlation of transjugular liver biopsy with magnetic resonance and hemodynamics. Congenital Heart Disease. 14(4). 600–608. 60 indexed citations

Hersh, Elliot V., Lawrence M. Levin, Theodore A. Kiersch, et al.. (2004). Dose-ranging analgesic study of prosorb® diclofenac potassium in postsurgical dental pain. Clinical Therapeutics. 26(8). 1215–1227. 44 indexed citations

Zuniga, John R., Ceib Phillips, Daniel A. Shugars, et al.. (2004). Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. Journal of Oral and Maxillofacial Surgery. 62(7). 806–815. 40 indexed citations

Peroutka, Stephen J., James A. Lyon, James Swarbrick, et al.. (2004). Efficacy of Diclofenac Sodium Softgel 100 mg With or Without Caffeine 100 mg in Migraine Without Aura: A Randomized, Double‐blind, Crossover Study. Headache The Journal of Head and Face Pain. 44(2). 136–141. 30 indexed citations

Golden, Pamela L., et al.. (1994). Effects of Probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in humans. Clinical Pharmacology & Therapeutics. 56(2). 133–141. 1 indexed citations

McLeod, Donald C. & James A. Lyon. (1985). Imipenem/Cilastatin: The First Carbapenem Antibiotic. Drug Intelligence & Clinical Pharmacy. 19(12). 894–899. 27 indexed citations

Muder, Robert R., et al.. (1984). Penetration of cefoperazone into surgical wound drainage in patients undergoing head and neck surgery. Antimicrobial Agents and Chemotherapy. 25(4). 473–475. 1 indexed citations

Garzone, Pamela D., James A. Lyon, & Victor L. Yu. (1983). Third-Generation and Investigational Cephalosporins: I. Structure-Activity Relationships and Pharmacokinetic Review. Drug Intelligence & Clinical Pharmacy. 17(7-8). 507–515. 36 indexed citations

10.

Jackson, Eric A., Alex A. Cardoni, & James A. Lyon. (1983). Cefoperazone (Cefobid, Pfizer). Drug Intelligence & Clinical Pharmacy. 17(1). 7–11. 10 indexed citations

11.

Garzone, Pamela D., James A. Lyon, & Victor L. Yu. (1983). Third-Generation and Investigational Cephalosporins: II. Microbiologic Review and Clinical Summaries. Drug Intelligence & Clinical Pharmacy. 17(9). 615–622. 27 indexed citations

12.

Lyon, James A., et al.. (1982). Comparable serum salicylate concentrations from choline magnesium trisalicylate, aspirin, and buffered aspirin in rheumatoid arthritis. Arthritis & Rheumatism. 25(4). 464–466. 3 indexed citations

13.

Garzone, Pamela D., et al.. (1981). Steady-state moxalactam kinetics: Comparisons with other cephalosporins. Clinical Pharmacology & Therapeutics. 30(1). 86–94. 7 indexed citations

14.

Diven, Warren F., Boyd D. Obermeyer, Robert L. Wolen, et al.. (1981). Measurement of Serum and Tissue Concentration of Moxalactam Using High Pressure Liquid Chromatography. Therapeutic Drug Monitoring. 3(3). 291–296. 12 indexed citations

15.

Lyon, James A., et al.. (1960). Mandibulofacial Dysostosis. Radiology. 74(2). 225–231. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact